Hallucinations in AI: How GSK is addressing a critical problem in drug development
GSK(GSK) VentureBeat·2025-01-15 07:13
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Generative AI has become a key piece of infrastructure in many industries, and healthcare is no exception. Yet, as organizations like GSK push the boundaries of what generative AI can achieve, they face significant challenges — particularly when it comes to reliability. Hallucinations, or when AI models generate incorrect or fabricated information, are a persistent problem in high-s ...